Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Hepatology. 2015 Jun 26;62(3):773–783. doi: 10.1002/hep.27869

Table 3.

Linear Regression Analysis for the Association of NAFLD with Continuous Markers of Subclinical Myocardial Dysfunction, The CARDIA Study, 2010-2011

Model 1: Base modela Model 2: Base + HF risk factorsb Model 3: Base + BMI Model 4: Base + VAT Model 5: Base + HF risk factors + BMI Model 6: Base + HF risk factors + VAT
β (SE) P value β (SE) P value β (SE) P value β (SE) P value β (SE) P value β (SE) P value
Cardiac Dimensions
LV mass indexc 5.8 (0.8) <0.0001 2.8 (0.8) 0.0004 0.8 (0.7) 0.24 1.4 (0.8) 0.08 0.09 (0.72) 0.90 0.42 (0.80) 0.60
LV end-diastolic volume −1.9 (1.8) 0.03 −2.2 (1.9) 0.24 −7.1 (1.8) <0.0001 −4.0 (2.0) 0.04 −8.1 (1.83) <0.0001 −5.5 (2.0) 0.006
Left atrial volume indexd 1.9 (0.6) 0.001 0.6 (0.6) 0.34 −1.6 (0.6) 0.004 −0.7 (0.6) 0.28 −1.6 (0.60) 0.005 −0.9 (0.63) 0.15
LV systolic myocardial function
Absolute GLS −0.93 (0.16) <0.0001 −0.58 (0.17) 0.0005 −0.59 (0.17) 0.0005 −0.42 (0.18) 0.02 −0.34 (0.17) 0.04 −0.27 (0.18) 0.05
LV diastolic myocardial function
E/A ratio −0.13 (0.02) <0.0001 −0.06 (.02) 0.008 −0.07 (0.02) 0.003 −0.03 (0.03) 0.26 −0.04 (0.02) 0.14 −0.008 (0.03) 0.75
E/e’ ratio 0.80 (0.15) <0.0001 0.34 (.15) 0.03 0.35 (0.15) 0.004 0.35 (0.16) 0.03 0.20 (0.15) 0.20 0.16 (0.16) 0.31
Lateral tissue Doppler e’ velocity −0.77 (0.14) <0.0001 −0.34 (.14) 0.02 −0.32 (0.15) 0.0004 −0.36 (0.15) 0.02 −0.28 (0.15) 0.05 −0.22 (0.15) 0.05
Hemodynamic variables
Cardiac output .78 (.11) <0.0001 0.41 (0.11) 0.0002 0.27 (0.11) 0.01 0.22 (0.11) 0.06 0.12 (0.11) 0.27 0.08 (0.11) 0.47

Abbreviations: GLS, global longitudinal strain; HF, heart failure; BMI, body mass index; VAT, visceral adipose tissue; LV, left ventricle

NAFLD is defined as CT liver attenuation ≤ 40 HU

a

Base model: center, age, race, sex, education, income level, alcohol intake (drinks/week), smoking status (current/former vs. never), physical activity score

b

HF risk factors: systolic blood pressure, antihypertensive medication use, anti-hyperlipidemic medication use, total cholesterol, HDL cholesterol, diabetes status, GFR

c

Indexed to height2.7

d

Indexed to height